首页|加味清胰汤保留灌肠联合奥曲肽治疗急性胰腺炎患者的效果

加味清胰汤保留灌肠联合奥曲肽治疗急性胰腺炎患者的效果

扫码查看
目的:观察加味清胰汤保留汤灌肠联合奥曲肽治疗急性胰腺炎患者的效果.方法:回顾性分析 2022 年 6 月至 2023 年10 月该院收治的 96 例急性胰腺炎患者的临床资料,按照治疗方法不同将其分为对照组与观察组各 48 例.对照组采用醋酸奥曲肽注射液治疗,观察组在对照组基础上联合加味清胰汤保留灌肠治疗.比较两组临床疗效,症状缓解时间,治疗前后病情程度[改良CT严重指数(MCTSI)、急性生理与慢性健康评分系统Ⅱ(APACHEⅡ)]评分及血清炎性因子[肝素结合蛋白(HBP)、高迁移率族蛋白B1(HMGB1)]水平,以及不良反应发生率.结果:观察组治疗总有效率为95.83%(46/48),高于对照组的83.33%(40/48),差异有统计学意义(P<0.05);治疗后,观察组MCTSI、APACHE Ⅱ评分及血清HBP、HMGB1 水平均低于对照组,腹痛消失时间、腹胀消失时间、血清淀粉酶复常时间均短于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:加味清胰汤保留灌肠联合奥曲肽治疗急性胰腺炎患者效果确切,可加快症状缓解,降低MCTSI、APACHE Ⅱ评分和血清HBP、HMGB1 水平,效果优于单用奥曲肽治疗.
Effects of modified Qingyi decoction retention enema combined with Octreotide on acute pancreatitis
Objective:To observe effects of modified Qingyi decoction retention enema combined with Octreotide on acute pancreatitis.Methods:The clinical data of 96 patients with acute pancreatitis admitted to this hospital from June 2022 to October 2023 were retrospectively analyzed.According to different treatment methods,they were divided into control group and observation group,48 cases in each group.The control group was treated with Octreotide acetate injection,while the observation group was treated with modified Qingyi decoction retention enema on the basis of that of the control group.The clinical efficacy,the symptom relief time,the disease severity[modified CT severity index(MCTSI),acute physiology and chronic health evaluation II(APACHE II)]score and the serum inflammatory factors[heparin binding protein(HBP),high mobility group protein B1(HMGB1)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 95.83%(46/48),which was higher than 83.33%(40/48)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the MCTSI and APACHE II scores as well as the serum HBP and HMGB1 levels in the observation group were lower than those in the control group,the disappearance time of abdominal pain,the disappearance time of abdominal distension and the recovery time of serum amylase were shorter than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Modified Qingyi decoction retention enema combined with Octreotide is effective in the treatment of the patients with acute pancreatitis,which can accelerate the symptom relief,reduce the MCTSI and APACHE II scores and the serum HBP and HMGB1 levels.Moreover,it is superior to simple Octreotide treatment.

Acute pancreatitisQingyi decoctionOctreotideRetention enemaHeparin binding proteinHigh mobility group protein B1

韩锋霞、王红辉

展开 >

郑州市金水区总医院消化科,河南 郑州 450003

急性胰腺炎 清胰汤 奥曲肽 保留灌肠 肝素结合蛋白 高迁移率族蛋白B1

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(18)